Edesa Biotech Inc (EDSA)
2.17
+0.06
(+2.84%)
USD |
NASDAQ |
Nov 22, 16:00
2.17
0.00 (0.00%)
After-Hours: 19:28
Edesa Biotech Total Liabilities (Quarterly): 2.361M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.361M |
| March 31, 2024 | 2.151M |
| December 31, 2023 | 1.987M |
| September 30, 2023 | 1.842M |
| June 30, 2023 | 1.569M |
| March 31, 2023 | 1.674M |
| December 31, 2022 | 1.401M |
| September 30, 2022 | 2.184M |
| June 30, 2022 | 5.704M |
| March 31, 2022 | 3.383M |
| December 31, 2021 | 1.794M |
| September 30, 2021 | 1.526M |
| June 30, 2021 | 1.074M |
| March 31, 2021 | 4.729M |
| December 31, 2020 | 2.406M |
| September 30, 2020 | 4.131M |
| June 30, 2020 | 3.581M |
| March 31, 2020 | 0.7017M |
| December 31, 2019 | 0.8557M |
| June 30, 2019 | 1.015M |
| March 31, 2019 | 0.8814M |
| December 31, 2018 | 0.592M |
| September 30, 2018 | 0.4934M |
| June 30, 2018 | 0.4146M |
| March 31, 2018 | 0.5898M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.5744M |
| September 30, 2017 | 0.3209M |
| June 30, 2017 | 0.4253M |
| March 31, 2017 | 0.4334M |
| December 31, 2016 | 0.6021M |
| September 30, 2016 | 0.6236M |
| June 30, 2016 | 0.839M |
| March 31, 2016 | 0.6161M |
| December 31, 2015 | 0.7237M |
| September 30, 2015 | 2.381M |
| June 30, 2015 | 1.780M |
| March 31, 2015 | 2.904M |
| December 31, 2014 | 4.189M |
| August 31, 2014 | 6.773M |
| May 31, 2014 | 4.352M |
| February 28, 2014 | 7.404M |
| November 30, 2013 | 9.036M |
| August 31, 2013 | 10.71M |
| May 31, 2013 | 5.351M |
| February 28, 2013 | 4.597M |
| November 30, 2012 | 1.476M |
| August 31, 2012 | 0.6923M |
| May 31, 2012 | 0.4851M |
| February 29, 2012 | 0.6723M |
| November 30, 2011 | 1.139M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.7017M
Minimum
Mar 2020
5.704M
Maximum
Jun 2022
2.371M
Average
1.987M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 161.36M |
| Lexaria Bioscience Corp | 0.2714M |
| Xenon Pharmaceuticals Inc | 38.09M |
| ESSA Pharma Inc | 3.805M |
| ImmunoPrecise Antibodies Ltd | 19.09M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.228M |
| Shareholders Equity (Quarterly) | 2.867M |